VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

Pauline Lemmens  ¹     João Sabino  ¹     Edouard Louis  ²     Wouter Van Moerkercke  ³     Lieven Pouillon  ⁴     Michaël Somers  ⁵     Harald Peeters  ⁶     Stijn Dr. Vanden Branden  ⁷     Julie Busschaert     Filip Baert     Anneline Cremer     Philippe Potvin     Sophie Dewit     Arnaud Colard     Jo Swinnen     Guy Lambrecht     Christophe Claessens     Barbara Willandt     Pieter Dewint     Evi    
¹ University Hospital Leuven, Leuven, Belgium
² CHU Liège and Liège University, Liège, Belgium
³ AZ Groeninge, Kortrijk, Belgium
⁴ Imelda Hospital, Bonheiden, Belgium
⁵ University Hospital Antwerp, Antwerp, Belgium
⁶ University Hospital Gent, Gent, Belgium
⁷ Onze Lieve Vrouw Hospital, Aalst, Belg

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)